AI Enables “Predict-to-Prescribe” Approach for Children Receiving Cochlear Implants
A deep transfer learning AI model predicted spoken language outcomes in children one to three years after cochlear implantation with 92% accuracy.
A deep transfer learning AI model predicted spoken language outcomes in children one to three years after cochlear implantation with 92% accuracy.
A recent study of outcomes in infants and young deaf children with cochlear implants suggests that socioeconomic status plays a major role in whether spoken language becomes their primary communication mode.
Angela Bonino, PhD, discusses her research on the lack of access to adequate hearing assessments for children with developmental disabilities.
We need to increase awareness about testing for cCMV so this cause of non-genetic deafness in newborns can be diagnosed and treated.
Read MoreThe clinical innovation lab is improving the use of 3D printing for custom pediatric hearing aid earmolds to significantly improve efficiency in patient care.
Read MoreUnitedHealthcare has expanded its coverage of cochlear implants to include children as young as 6 months effective Sept. 1, 2024.
Read MoreThe International Pediatric Conference, to be held this October 2024, will bring together global experts to discuss childhood hearing loss.
Read MoreThe ADHS and the Arizona Commission for the Deaf and the Hard of Hearing received a grant to enhance early pediatric hearing screening.
Read MoreThe plan aims to enhance access to pediatric audiology and Listening and Spoken Language services for children who are deaf or hard of hearing.
Read MoreThe HEAR program is a text messaging service supporting families of children with hearing loss through expert advice and community connection.
Read MoreWhile it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests.
Read MoreA look at advancements in pediatric hearing aids and advice to enhance the fitting experience for younger patients and their HCPs.
Read MoreThe clinical trial will test a gene therapy drug to treat children with a form of hereditary deafness caused by mutations in the OTOF gene.
Read MoreResearchers found the novel gene therapy to be an effective treatment for patients with a specific form of autosomal recessive deafness.
Read MoreTemporary hearing loss from ear infections can lead to deficits in auditory processing and language development in children years later.
Read MoreAccording to the legislation, coverage includes one hearing aid per ear, up to a cost of $1,500, every 24 months.
Read MoreAcclarent received FDA clearance for its pediatric Eustachian Tube Balloon Dilation System in the treatment of children.
Read MoreThe ACLU of Delaware alleges current practices violate the Americans with Disabilities Act and Section 504 of the Rehabilitation Act.
Read More